-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $258

Benzinga·02/24/2026 14:22:30
Listen to the news
Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $243 to $258.